Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction.
Katoh S, Shishido T, Kutsuzawa D, Arimoto T, Netsu S, Funayama A, Ishino M, Niizeki T, Nishiyama S, Takahashi H, Miyashita T, Miyamoto T, Nitobe J, Watanabe T, Kubota I.
Katoh S, et al. Among authors: kutsuzawa d.
Ann Nucl Med. 2010 Nov;24(9):679-86. doi: 10.1007/s12149-010-0409-3. Epub 2010 Sep 8.
Ann Nucl Med. 2010.
PMID: 20824398
Clinical Trial.